A COST-EFFECTIVENESS ANALYSIS OF THE FIRST-LINE TREATMENT REGIMENS FOR MULTIPLE MYELOMA IN MACAO CHINA

被引：0
|
作者：
Lee, K. K. [1 ]
Lee, V. W. [1 ]
Kuok, K. C. [2 ]
机构：
[1] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
[2] Macao Polytech, Macao, Peoples R China
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)72154-9
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A35 / A36
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness of novel first-line treatment regimens for tuberculosis
    Owens, J. P.
    Fofana, M. O.
    Dowdy, D. W.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013, 17 (05) : 590 - 596
  • [2] COST-EFFECTIVENESS OF OLANZAPINE IN THE FIRST-LINE TREATMENT OF SCHIZOPHRENIA IN CHINA
    Zhao, J.
    Jiang, K.
    Li, Q.
    Zhang, Y. L.
    Cheng, Y.
    Lin, Z.
    Xuan, J.
    [J]. VALUE IN HEALTH, 2018, 21 : S76 - S77
  • [3] Cost-effectiveness of olanzapine in the first-line treatment of schizophrenia in China
    Zhao, Jingping
    Jiang, Kaida
    Li, Qingwei
    Zhang, Yanlei
    Cheng, Yan
    Lin, Ziyi
    Xuan, Jianwei
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (05) : 439 - 446
  • [4] Cost-effectiveness analysis of first-line treatment for chronic hepatitis B in China
    Dai, Zonglin
    Wong, Irene O. L.
    Xie, Chan
    Xu, Wenxiong
    Xiang, Yu
    Peng, Liang
    Lau, Eric H. Y.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (02) : 300.e1 - 300.e8
  • [5] Cost-effectiveness of high-dose chemotherapy in first-line treatment of advanced multiple myeloma
    Sampson, FC
    Beard, SM
    Scott, F
    Vandenberghe, E
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (04) : 1015 - 1019
  • [6] Cost-effectiveness analysis of first-line HAART
    Maggiolo, F.
    Di Matteo, S.
    Masini, G.
    Astuti, N.
    Di Filippo, E.
    Bernardini, C.
    Soavi, L.
    Colombo, G.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 69 - 70
  • [7] The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation
    Picot, J.
    Cooper, K.
    Bryant, J.
    Clegg, A. J.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2011, 15 (41) : 1 - +
  • [8] A cost-effectiveness analysis of Onabotulinumtoxin A as first-line treatment for overactive bladder
    Jonathan P. Shepherd
    Charelle M. Carter-Brooks
    Christopher Chermanksy
    [J]. International Urogynecology Journal, 2018, 29 : 1213 - 1219
  • [9] A Cost-Effectiveness Analysis of Onabotulinumtoxin A as First-Line Treatment for Overactive Bladder
    不详
    [J]. OBSTETRICAL & GYNECOLOGICAL SURVEY, 2018, 73 (11) : 629 - 630
  • [10] A cost-effectiveness analysis of Onabotulinumtoxin A as first-line treatment for overactive bladder
    Shepherd, Jonathan P.
    Carter-Brooks, Charelle M.
    Chermanksy, Christopher
    [J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2018, 29 (08) : 1213 - 1219
12345